- Home
- COCP vs AQMS Comparison
COCP vs AQMS Comparison
Compare COCP & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- AQMS
- Stock Information
- Founded
- COCP N/A
- AQMS 2014
- Country
- COCP United States
- AQMS United States
- Employees
- COCP N/A
- AQMS N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- AQMS Metal Fabrications
- Sector
- COCP Health Care
- AQMS Industrials
- Exchange
- COCP Nasdaq
- AQMS Nasdaq
- Market Cap
- COCP 18.2M
- AQMS 18.0M
- IPO Year
- COCP N/A
- AQMS 2015
- Fundamental
- Price
- COCP $2.04
- AQMS $0.15
- Analyst Decision
- COCP Strong Buy
- AQMS Strong Buy
- Analyst Count
- COCP 1
- AQMS 2
- Target Price
- COCP $7.00
- AQMS $1.50
- AVG Volume (30 Days)
- COCP 18.6K
- AQMS 664.0K
- Earning Date
- COCP 11-11-2024
- AQMS 11-06-2024
- Dividend Yield
- COCP N/A
- AQMS N/A
- EPS Growth
- COCP N/A
- AQMS N/A
- EPS
- COCP N/A
- AQMS N/A
- Revenue
- COCP N/A
- AQMS $25,000.00
- Revenue This Year
- COCP N/A
- AQMS N/A
- Revenue Next Year
- COCP N/A
- AQMS N/A
- P/E Ratio
- COCP N/A
- AQMS N/A
- Revenue Growth
- COCP N/A
- AQMS 525.00
- 52 Week Low
- COCP $1.33
- AQMS $0.14
- 52 Week High
- COCP $3.10
- AQMS $1.01
- Technical
- Relative Strength Index (RSI)
- COCP 61.73
- AQMS 33.13
- Support Level
- COCP $1.66
- AQMS $0.15
- Resistance Level
- COCP $1.87
- AQMS $0.18
- Average True Range (ATR)
- COCP 0.15
- AQMS 0.02
- MACD
- COCP 0.04
- AQMS 0.00
- Stochastic Oscillator
- COCP 48.10
- AQMS 11.23
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.